184 related articles for article (PubMed ID: 27437087)
21. In vitro evaluation of the inhibition potential of echinacoside on human cytochrome P450 isozymes.
Wu Y; Qiao A; Lin S; Chen L
BMC Complement Med Ther; 2022 Feb; 22(1):46. PubMed ID: 35180866
[TBL] [Abstract][Full Text] [Related]
22. The inhibitory activity of the extracts of popular medicinal herbs on CYP1A2, 2C9, 2C19 and 3A4 and the implications for herb-drug interaction.
Fasinu PS; Bouic PJ; Rosenkranz B
Afr J Tradit Complement Altern Med; 2014; 11(4):54-61. PubMed ID: 25392581
[TBL] [Abstract][Full Text] [Related]
23. Identification of the human liver cytochrome P450 isoenzymes responsible for the 5-methylhydroxylation of the novel anti-fibrotic drug AKF-PD.
He X; Luo X; Liu Z; Hu G; Cheng Z
Xenobiotica; 2011 Oct; 41(10):844-50. PubMed ID: 21679010
[TBL] [Abstract][Full Text] [Related]
24. Effect of probucol on cytochrome P450 activities in human liver microsomes.
Umehara K; Shimokawa Y; Miyamoto G
Biol Pharm Bull; 2002 Aug; 25(8):1112-4. PubMed ID: 12186421
[TBL] [Abstract][Full Text] [Related]
25. In vitro Inhibitory Effects of Isofraxidin on Human Liver Cytochrome P450 Enzymes.
Song X; Dong G; Zhou Y
Pharmacology; 2019; 103(3-4):120-127. PubMed ID: 30544127
[TBL] [Abstract][Full Text] [Related]
26. Effect of eugenol on cytochrome P450 1A2, 2C9, 2D6, and 3A4 activity in human liver microsomes.
Alharbi NFM; Ahad A; Bin Jardan YA; Al-Jenoobi FI
Saudi Pharm J; 2024 Jul; 32(7):102118. PubMed ID: 38841106
[TBL] [Abstract][Full Text] [Related]
27. Identification of human cytochrome P450 isoforms involved in the metabolism of S-2-[4-(3-methyl-2-thienyl)phenyl]propionic acid.
Taguchi K; Konishi T; Nishikawa H; Kitamura S
Xenobiotica; 1999 Sep; 29(9):899-907. PubMed ID: 10548450
[TBL] [Abstract][Full Text] [Related]
28. Metabolism of sesamin by cytochrome P450 in human liver microsomes.
Yasuda K; Ikushiro S; Kamakura M; Ohta M; Sakaki T
Drug Metab Dispos; 2010 Dec; 38(12):2117-23. PubMed ID: 20851877
[TBL] [Abstract][Full Text] [Related]
29. The gastroprokinetic and antiemetic drug metoclopramide is a substrate and inhibitor of cytochrome P450 2D6.
Desta Z; Wu GM; Morocho AM; Flockhart DA
Drug Metab Dispos; 2002 Mar; 30(3):336-43. PubMed ID: 11854155
[TBL] [Abstract][Full Text] [Related]
30. Identification of human cytochrome P450 isoforms involved in the 3-hydroxylation of quinine by human live microsomes and nine recombinant human cytochromes P450.
Zhao XJ; Yokoyama H; Chiba K; Wanwimolruk S; Ishizaki T
J Pharmacol Exp Ther; 1996 Dec; 279(3):1327-34. PubMed ID: 8968357
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of potential herb-drug interactions based on the effect of Suxiao Jiuxin Pill on CYP450 enzymes and transporters.
Qiang T; Li Y; Wang K; Lin W; Niu Z; Wang D; Wang X
J Ethnopharmacol; 2021 Nov; 280():114408. PubMed ID: 34252529
[TBL] [Abstract][Full Text] [Related]
32. Investigation of the inhibition of eight major human cytochrome P450 isozymes by a probe substrate cocktail
Valicherla GR; Mishra A; Lenkalapelly S; Jillela B; Francis FM; Rajagopalan L; Srivastava P
Xenobiotica; 2019 Dec; 49(12):1396-1402. PubMed ID: 30747554
[TBL] [Abstract][Full Text] [Related]
33.
Ding B; Ji X; Sun X; Zhang T; Mu S
Xenobiotica; 2020 Aug; 50(8):913-918. PubMed ID: 32026737
[TBL] [Abstract][Full Text] [Related]
34. Identification of human cytochrome P450 isoforms involved in the stereoselective metabolism of mianserin enantiomers.
Koyama E; Chiba K; Tani M; Ishizaki T
J Pharmacol Exp Ther; 1996 Jul; 278(1):21-30. PubMed ID: 8764331
[TBL] [Abstract][Full Text] [Related]
35. Evidence for cytochrome P450 2A6 and 3A4 as major catalysts for N'-nitrosonornicotine alpha-hydroxylation by human liver microsomes.
Patten CJ; Smith TJ; Friesen MJ; Tynes RE; Yang CS; Murphy SE
Carcinogenesis; 1997 Aug; 18(8):1623-30. PubMed ID: 9276639
[TBL] [Abstract][Full Text] [Related]
36.
Li M; Liu X; Wang Y; Ju X
Xenobiotica; 2020 Oct; 50(10):1202-1207. PubMed ID: 32338127
[TBL] [Abstract][Full Text] [Related]
37. Studies of flurbiprofen 4'-hydroxylation. Additional evidence suggesting the sole involvement of cytochrome P450 2C9.
Tracy TS; Marra C; Wrighton SA; Gonzalez FJ; Korzekwa KR
Biochem Pharmacol; 1996 Oct; 52(8):1305-9. PubMed ID: 8937439
[TBL] [Abstract][Full Text] [Related]
38. Prediction of cytochrome P450-mediated drug clearance in humans based on the measured activities of selected CYPs.
Gao J; Wang J; Gao N; Tian X; Zhou J; Fang Y; Zhang HF; Wen Q; Jia LJ; Zou D; Qiao HL
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29054967
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of Herb-Drug Interaction of Synacinn™ and Individual Biomarker through Cytochrome 450 Inhibition Assay.
Ab Rahman NS; Abd Majid FA; Abd Wahid ME; Zainudin AN; Zainol SN; Ismail HF; Wong TS; Tiwari NK; Giri S; Bhargava V
Drug Metab Lett; 2018; 12(1):62-67. PubMed ID: 29542427
[TBL] [Abstract][Full Text] [Related]
40. Identification of human cytochrome P450 isoforms involved in the metabolism of brotizolam.
Senda C; Kishimoto W; Sakai K; Nagakura A; Igarashi T
Xenobiotica; 1997 Sep; 27(9):913-22. PubMed ID: 9381732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]